Catalyst Wire Dossier Catalyst Wire Dossier

BNT351

· BioNTech SE
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT351, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV [Phase 1]

See pricing